Forma Therapeutics Holdings, Inc.

FMTXDelisted Oct 14, 2022

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001538927

SEC filings (opens in a new tab)

Forma Therapeutics Holdings, Inc. was delisted on Oct 14, 2022; its insiders filed their last Form 4 on Oct 14, 2022; 139 institutions reported holding it in 13F filings for Q3 2022, worth $835.0M in total; HHLR Advisors (Hillhouse) was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Forma Therapeutics Holdings, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of FMTX: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	98	3	106	+11
Shares	41.7M	71.7K	41.7M	+89.6K (+0.2%)
Value	$387.7M	$667.0K	$287.5M	−$99.6M (−25.7%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to FMTX in Q2 2022
Institution	Shares	Value	% of portfolio
Caxton Associates LP	204,594	$1.41M	0.18%
Prudential Financial Inc	107,135	$738.0K	0.00%
Acadian Asset Management LLC	62,956	$434.0K	0.00%
Opaleye Management Inc.	58,700	$404.0K	0.18%
Marshall Wace, LLP	34,142	$236.0K	0.00%
AQR Capital Management LLC	34,037	$235.0K	0.00%
Healthcare of Ontario Pension Plan Trust Fund	34,000	$234.0K	0.00%
Thrivent Financial for Lutherans	32,740	$226.0K	0.00%
Occudo Quantitative Strategies LP	32,459	$224.0K	0.02%
Trexquant Investment LP	29,315	$202.0K	0.01%
Schonfeld Strategic Advisors LLC	25,700	$177.0K	0.00%
Cornercap Investment Counsel Inc	23,747	$164.0K	0.03%
Gryphon Financial Partners LLC	18,993	$131.0K	0.03%
Man Group plc	–	$98.0K	0.00%
Pinnacle Wealth Planning Services, Inc.	12,596	$87.0K	0.02%
Balyasny Asset Management LLC	11,082	$76.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	10,917	$75.0K	0.00%
Centiva Capital, LP	10,332	$71.0K	0.00%
Point72 Hong Kong Ltd	616	$4.00K	0.00%
The PNC Financial Services Group, Inc.	246	$2.00K	0.00%
Quadrant Capital Group LLC	245	$2.00K	0.00%
Captrust Financial Advisors	133	$1.00K	0.00%

Sold out (11)

Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of FMTX in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Artal Group S.A.	1,000,000	$9.30M
Point72 Asset Management, L.P.	561,500	$5.22M
Rafferty Asset Management, LLC	168,210	$1.56M
Bollard Group LLC	158,200	$1.47M
Jump Financial, LLC	39,252	$365.0K
Gsa Capital Partners LLP	16,845	$157.0K
Price T Rowe Associates Inc	16,795	$156.0K
ProShare Advisors LLC	11,275	$105.0K
Virtus ETF Advisers LLC	11,234	$104.0K
Quantbot Technologies LP	3,600	$33.0K
State of Wyoming	131	$1.00K

Not filed for Q2 2022 yet (3)

Institutions that held Forma Therapeutics Holdings, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FMTX in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Susquehanna Fundamental Investments, LLC	57,275	$533.0K
Parametric Portfolio Associates LLC	10,291	$96.0K
Amalgamated Financial Corp.	4,107	$38.0K